Control of stem cell fate to either enter terminal differentiation versus returning to quiescence (self-renewal) is crucial for tissue repair. Here, we showed that AMP-activated protein kinase (AMPK), the master metabolic regulator of the cell, controls muscle stem cell (MuSC) self-renewal. AMPKa1 
Introduction
Many aspects of cell physiology are differently regulated in adult stem cells as compared with other types of cells. Maintenance of the quiescent state, which is a reversible state of growth arrest, is a fundamental process that maintains the number and function of selfrenewing cells (Orford & Scadden, 2008) . In eukaryotes, quiescence is defined not only in relation to the cell cycle but also as a metabolically unique state characterized by suppressed catabolism resulting in a non-dividing phase (Laporte et al, 2011) . Thus, establishment of quiescence via altered metabolic activity can be an effective strategy to survive in extreme conditions such as starvation or hypoxia (Takubo et al, 2013) . For example, adult hematopoietic stem cells (HSCs) rely primarily on glycolysis to generate ATP (Rafalski et al, 2012) , have relatively little cytoplasm and are less dependent on mitochondrial oxygen-consuming metabolism (Kim et al, 1998) than more differentiated cells (Simsek et al, 2010) . In this context, an outstanding question is how specific changes in metabolic flux affect stem cell fate and stemness. This is an issue that adult muscle stem cells (MuSCs) are uniquely well suited to address.
Indeed, MuSCs are a very well-defined model of adult stem cells. Their capacity to repair skeletal muscle fiber (myofiber) and to sustain skeletal muscle regeneration during the entire lifespan, as well as their capability to self-renew to maintain the pool of quiescent MuSCs, is crucial for skeletal muscle homeostasis. At steady state, MuSCs (satellite cells) lay quiescent in their niche along the myofiber where they express the transcription factor Pax7 (Seale et al, 2000) . Upon muscle injury, they become activated into transitory amplifying cells and proliferate while expressing Pax7, Myf5, and MyoD. Then, MuSCs either enter terminal myogenic differentiation-during which they down-regulate Pax7, increase MyoD and myogenin expression, and fuse to form new myofibers-or selfrenew and return to quiescence that is associated with downregulation of MyoD and increase of Pax7 expression (Kuang et al, 2007) . Stemness of MuSCs is very powerful since one grafted single myofiber (containing about seven satellite cells) gives rise to over 100 new myofibers containing new quiescent MuSCs and about 25-30,000 nuclei as well (Collins et al, 2005) .
The metabolism of MuSCs is poorly understood, although these cells seem to rely more on glycolysis than oxidative phosphorylation for energy production during early activation (Cerletti et al, 2012; Ryall et al, 2015) . MuSCs expressing high level of Pax7 exhibit a low metabolic state, highly express stem-like markers, and are slow to divide after their exit from quiescence . Recently, it has been suggested that the resistance to severe hypoxia could be considered as an intrinsic characteristic of some MuSCs, which have developed the capacity to reduce their metabolic activity and adopt a more quiescent/ dormant state under extreme conditions of stress (Latil et al, 2012) . In other stem cell systems, such as HSCs, regulation of stem cell fate has been linked to their metabolism (Ito et al, 2012; Knobloch et al, 2013) , particularly the exit from and the entry into the quiescent state (Rafalski et al, 2012) . 5 0 -AMP-activated protein kinase (AMPK) is a master regulator of metabolic homeostasis (Hardie et al, 2012) and a negative regulator of glucose metabolism in cancer cells (i.e., "Warburg effect") (Faubert et al, 2013) . In almost all cell types, AMPK regulates the balance between catabolic and anabolic processes, particularly in skeletal muscle cells in which it controls myofiber growth and size (Mounier et al, 2009 (Mounier et al, , 2011 Lantier et al, 2010) . AMPK pathway regulates macrophage inflammatory state during skeletal muscle regeneration, linking metabolism, and inflammation (Mounier et al, 2013) . It also controls the polarity of some cell types (Hardie, 2011) . Moreover, AMPK has been shown to regulate cell growth by phosphorylation of effectors controlling the cell cycle (Hardie, 2011) . However, its action on stem cell fate has not been investigated. Recently, it has been suggested that AMPKa1-deficient MuSCs rely more on oxidative metabolism at the time of their activation (Fu et al, 2015) . However, the genetic mouse model used in this study relies on a different exon deletion of prkaa1 (AMPKa1) gene (exon 3 versus exons 4 and 5 in the present study) and on a different Cre driver (B6.129S-Pax7tm1(cre/ERT2)Gaka/J mouse versus B6;129-Pax7tm2.1(cre/ERT2)Fan/J mouse in the present study), rendering the role of AMPK in MuSC fate still unresolved. Identifying whether and how metabolism regulates MuSC fate (activation, proliferation, differentiation and self-renewal) is of importance for understanding the regulation of skeletal muscle homeostasis. Recent advances in MuSC biology have identified their fundamental biological roles and have fostered the development of tools to analyze MuSCs, enabling the investigation of their metabolic functions. The sequential steps of MuSC fate can be finely monitored in vivo, ex vivo, and in vitro, rendering MuSCs and muscle regeneration a powerful model to explore mechanisms of self-renewal in adult stem cells. In this context, we performed a comprehensive investigation of the role of metabolism in the regulation of MuSC fate. For this purpose, we used various genetic mouse models and culture setups to explore the role of the master regulator of energy stress response pathway AMPKa1 in tailoring the metabolic make-up of MuSCs and in modulating their fate. Here, we evidenced a novel AMPKa1-lactate dehydrogenase (LDH) pathway in the return to quiescence of MuSCs.
Results
AMPKa1 deficiency in MuSCs increases their self-renewal in vitro and ex vivo Evaluation of AMPK activity in pure MuSC populations extracted from regenerating wild-type (WT) tibialis anterior (TA) muscles by cell sorting (CD45/CD31/Sca1 À CD34/a7int + cells, Fig EV1A) showed that AMPKa1 activity was present, whereas AMPKa2 activity was not detectable in MuSCs (Fig 1A) , confirming our previous results on undifferentiated myoblasts (Lantier et al, 2010) . MuSCs were induced to fully differentiate and then were labeled for Pax7 (quiescence), Ki67 (proliferation), and MyoD (commitment into myogenic lineage) expression. of the cells are cycling 6 h after plating, at the time of switch to differentiation medium (i.e., at time of the starting of the experiments) (Fig EV1B, panel "activation") . Conversely, a decrease of the fusion index in AMPKa1 À/À was observed (À15%, P = 0.059, Fig 1C and D) that cannot be explained only by the lower number of differentiated cells (Pax7 À Ki67/MyoD À cells) at the time of switch into differentiation medium (panel "activation", Fig EV1B) . In accordance with the absence of AMPKa2 activity in MuSCs, no difference in MuSC behavior was observed in AMPKa2 À/À versus WT MuSCs (Fig EV1C and D) . These observations were confirmed by ex vivo clonal lineage tracing of MuSCs in the myofiber niche (Abou-Khalil et al, 2009; Yin et al, 2013) . Indeed, after myofiber isolation, all Pax7 + MuSCs are activated and rapidly start to express MyoD (Zammit et al, 2004) . Single myofibers isolated from extensor digitorum longus (EDL) and plantaris muscles were cultured for 3 days. The number of Pax7 + MyoD À cells (self-renewing cells returned to quiescence) was strongly increased in AMPKa1 À/À cells as compared with WT cells in both EDL and plantaris muscles (+147%, P < 0.05 and +175%, P < 0.01, respectively) ( Fig 1E) .
AMPKa1 deficiency in MuSCs increases their self-renewal in vivo
To investigate in vivo the role of AMPKa1 in MuSC fate, we used the cardiotoxin (CTX) injury model to damage the TA muscle. It induces the activation of quiescent MuSCs, their proliferation (peak at day 3-4 post-injury), their entry into terminal differentiation and fusion into new myofibers, or their return to quiescence back into their niche (days 6-14), and final recovery of the skeletal muscle homeostasis (days 21-28) (Collins et al, 2005; Arnold et al, 2007; Abou-Khalil et al, 2009; Mounier et al, 2013; Parisi et al, 2015) . In Pax7-CreER The EMBO Journal AMPKa1-LDH regulates muscle stem cell fate Marine Theret et al Fig 1F) . Quantitative PCR analysis confirmed the deletion of the pkraa1 (AMPKa1) gene in MuSCs before (day 0) and after CTX injury (day 28) (Fig EV1E) . To validate that the results were not unspecific effect mediated by tamoxifen injection (Brack, 2014) , control experiments were performed in adult Pax7-CreER T2/+ mice, where we verified that tamoxifen injections did not alter skeletal muscle regeneration (Fig EV1F-K) . In vivo experiments using Pax7-a1 À/À mice showed that 28 days after injury the percentage among MuSCs as well as the total number of quiescent Pax7 + Ki67/MyoD À MuSCs were remarkably increased in Pax7-a1 À/À muscles as compared with the control muscles (18%, P < 0.05 and 27%, P < 0.05, respectively; Fig 1G-I) . Conversely, the number of myonuclei per fiber (i.e., the result of differentiation and fusion of MuSCs) was decreased by 31% in Pax7-a1 À/À muscles (P < 0.001, Fig 2A) . This indicates that the number of differentiated cells capable of fusion dropped, consistent with the decrease of the fusion index observed in vitro in AMPKa1-deficient MuSCs (Fig 1C) . Histological analysis showed that skeletal muscle regeneration was altered in Pax7-a1 À/À mice.
Indeed, the cross-sectional area (CSA) of the regenerating myofibers in Pax7-a1 À/À mice was strikingly smaller in comparison with Pax7-a1 +/+ mice 28 days post-injury (À40%, P < 0.001, Fig 2B and C). Due to this decrease in myofiber size, a profound decrease in muscle mass was still observed 1 month after injury in Pax7-a1 À/À animals as compared with the Pax7-a1 +/+ animals (À19%, Fig 2D) . This important loss of mass was also noticed in gastrocnemius (GAS) muscles of Pax7-a1 À/À as compared with Pax7-a1 +/+ animals (À18.8%, P < 0.01, Fig EV2A) , showing that this effect was evident among different muscles with different metabolic characteristics. Intriguingly, the number of myofibers per muscle was remarkably increased in Pax7-a1 À/À muscles as compared with the control muscles (+55%, P < 0.001; Fig 2E) . A recent study suggests that a slow-dividing MuSC population retains long-term self-renewal potency (Ono et al, 2012 (Mounier et al, 2013) .
AMPKa1 deficiency in MuSC niche does not regulate MuSC homeostasis
Stem cells require cues from their microenvironment to regulate their fate (Morrison & Spradling, 2008) . In skeletal muscle, MuSCs lie quiescent along the myofiber in an anatomical niche that is critical for the maintenance of quiescence (Voog & Jones, 2010; Yin et al, 2013) . To decipher the influence that the microenvironment exerts on MuSCs, we studied HSA-Cre +/À :AMPKa1 fl/fl mice (HSAa1 À/À mice) in which AMPKa1 was specifically depleted in the myofiber (Miniou et al, 1999) (Fig EV2H) . We did not observe any phenotype in the HSA-a1 À/À mice after injury (Fig EV2D-G) , indicating that AMPKa1 expressed by the myofiber does not play a major role in the regulation of MuSC homeostasis, although it has major effects on the myofiber homeostasis/metabolism, as we previously reported (Mounier et al, 2009; Lantier et al, 2010) .
Altogether, these results demonstrate that AMPKa1 is a key regulator of adult MuSC fate and strongly support that AMPKa1 is involved in the negative regulation of MuSC self-renewal and/or could contribute in promoting myogenesis. Data information: Data are means AE SEM from at least three in vivo independent experiments. ***P < 0.001 versus Pax7-a1 +/+ . $ P < 0.05, $$ P < 0.01, $$$ P < 0.001 versus day 0 or day 1. Student's t-test. Scale bar = 50 lm. Data information: Data are means AE SEM from at least three independents in vitro or in vivo experiments. *P < 0.05, **P < 0.01 versus WT. $$ P = 0.01 versus day 0.
Student's t-test. Scale bar = 100 lm (D), 50 lm (I). (Gao & Cooper, 2013) . PKM2 promotes "aerobic glycolysis" (or Warburg effect), whereas PKM1 is associated with the oxidative metabolism (Christofk et al, 2008) . Recently, Ryall et al (2015) showed that expression of PKM2 isoform predominates over PKM1 isoform in cultured FACS-isolated satellite cells (Ryall et al, 2015) . In AMPKa1 À/À MPCs, pkm1 expression was decreased by 32% (P < 0.05), while pkm2 expression was increased by 48% (P < 0.05) as compared with WT MPCs (Fig 3A) , suggesting the use of a more glycolytic metabolism by AMPKa1 À/À MPCs. An increase in glycolysis in the absence of AMPKa1 was supported by the observation that AMPKa1 À/À MPCs exhibited higher lactate concentration as compared with WT MPCs after 24 h in standard differentiation medium (+57%, P < 0.05; Fig 3B) . To further characterize the role of AMPKa1 in the modulation of metabolism, we measured the oxygen consumption rate (OCR or "mitochondrial respiration", an indicator of mitochondrial oxidative activity) of MPCs. AMPKa1 À/À MPCs were not able to fully respond to an energetic stress induced by a bypass of the respiratory chain after incubation with carbonyl cyanide m-chlorophenylhydrazone (CCCP) (Leblanc, 1971) . Actually, OCR of WT MPCs was increased by 45% (P < 0.001), whereas mitochondrial respiration of AMPKa1 À/À MPCs was only increased by 19% after CCCP incubation (P < 0.05, Fig 3C and D) , suggesting that the total electron transport capacity was altered in the absence of AMPKa1. This triggered a difference of 1.23 fold between WT and AMPKa1 À/À MPC maximal respiration (P < 0.05, Fig 3D) , associated with no modifications of extracellular acidification rate in basal condition (ECAR, Fig EV3F) . This impairment of mitochondrial respiration of AMPKa1 À/À MPCs could be explained by a defect in mitochondrial biogenesis. Indeed, a significant decrease of pgc1a and pgc1b expression (À59%, P < 0.001 and À45%, P < 0.01, respectively; Fig 3E) , of citrate synthase (a critical enzyme of Krebs Cycle) activity (À31.8%, P < 0.001, Fig 3F) , and of the number of TOM22 (a core component of the mitochondrial outer membrane translocase) positive cells (À11%, P < 0.05, Fig EV3G) in AMPKa1 À/À MPCs as compared with WT MPCs was observed. As AMPK promotes the translocation to the plasma membrane of the glucose transporter mainly expressed in muscle cells (GLUT4) (Mounier et al, 2015) , we used a fluorescent glucose analogue, the 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose (2-NBDG), to examine glucose uptake. No difference in 2-NBDG accumulation within WT MPCs and AMPKa1 À/À MPCs was observed (Fig EV3D and E) ,
suggesting that the decreased oxidative metabolism in AMPKa1
MPCs is not due to altered glucose uptake.
Tailoring the metabolism modulates MuSC self-renewal in an AMPKa1-dependent pathway
To test whether metabolism can modulate self-renewal, we induced WT MuSCs to fully differentiate and quantified the return to quiescence (Pax7 + Ki67/MyoD À cells) in various culture media that drive different metabolism of the cells (Fig 3G-I ) (Gohil et al, 2010; Ryall et al, 2015) . Two days in low glucose (5 mM, LG) and high glucose (25 mM glucose and 1 mM pyruvate, HGP) concentrations were two conditions that allow cells to perform mainly glycolysis (Gohil et al, 2010; Ryall et al, 2015) (Fig 3G) , and here assessed by a high lactate concentration in the medium in both cell types (Fig EV3H) . By contrast, galactose condition (10 mM, Gal) drove cells to shift their metabolism toward oxidative phosphorylation (Figs 3G and EV3H) . Indeed, galactose has to be converted to glucose-6-phosphate for being further Data information: Data are means AE SEM from at least four in vitro independent experiments. *P < 0.05, **P < 0.01, ***P < 0.001 versus WT. # P < 0.05, ### P < 0.001 versus Basal OCR. The EMBO Journal AMPKa1-LDH regulates muscle stem cell fate Marine Theret et al metabolized through an ATP-consuming reaction. Therefore, cells incubated with galactose rely on oxidative phosphorylation to generate ATP (Ryall et al, 2015) . A non-glycolytic metabolism (Gal) markedly reduced WT MuSC self-renewal as compared with glycolytic conditions (À34%, P < 0.05 and À18% for LG and HGP, respectively) (Fig 3H and I) , proving that a shift from glycolysis to oxidative phosphorylation can negatively regulate the return to quiescence of MuSCs. Remarkably, this decrease in self-renewal was not observed in AMPKa1 À/À MuSCs (Fig 3H and   I ). Altogether, these results demonstrate, for the first time, that stem cell self-renewal can be modulated by shifting their metabolism in an AMPKa1-dependent pathway (Fig 3J) .
Activation of AMPKa1 regulates LDH activity and MuSC self-renewal
As LDH converts pyruvate into lactate, this enzyme is a defined regulator of aerobic glycolysis versus oxidative phosphorylation. LDH activity was increased in the absence of AMPKa1 in both MPCs and freshly isolated MuSCs (+73%, P < 0.05 and +142%, P < 0.01; respectively, Fig 4A and B) , whereas no modification of its expression at the mRNA level was observed (Fig 4C) . Interestingly, modification of LDH activity in the absence of AMPKa1 was also found in HSCs (LSK, Fig 4D) , but not in muscles in which AMPKa1 was specifically depleted in the myofiber (HSA-a1
, Figs 4E and EV4A). PK reaction is the last step in the glycolytic pathway, which produces pyruvate molecules that can be converted into lactate by LDH. In MPCs, the increase of LDH activity in the absence of AMPKa1 was not due to a higher PK activity (Fig EV4B) . Furthermore, AMPK activation with a potent and specific AMPK activator (compound 991) led to the inhibition of LDH activity in HeLa cells [a model chosen because MPCs are hardly transfected and because HeLa cells lack LKB1 (Tiainen et al, 1999) ] transfected with LDHA plasmid (Fig 4F) . Lastly, specific AMPK activation with compound 991 triggered the decrease of self-renewal in WT MuSCs (Fig 4G-I ) in a dose-dependent way, associated with a concomitant decrease of lactate concentration in the media (Fig 4H) . This was AMPKa1 dependent since AMPKa1 À/À cells did not respond to 991 (Fig EV4C) . These results indicate a role of AMPKa1 activity in the modulation of MuSC self-renewal through the regulation of its new functional target LDH.
Lactate dehydrogenase modulates MuSC self-renewal in vitro and in vivo
To evaluate the functional role of LDH on MuSC fate, we used oxamate, an allosteric inhibitor of LDH (Fig 5A) (Wilkinson & Walter, 1972) at concentrations shown to be efficient and non-toxic in mammalian cells (Ramanathan et al, 2005; Miskimins et al, 2014) . Incubation of MuSCs with increasing concentrations of oxamate induced a progressive decrease of LDH activity in MPCs ( Fig EV5A) and lactate concentration in MPC and MuSC supernatants (Fig EV5B and D) . Remarkably, inhibition of LDH activity led to a substantial decrease in self-renewal in WT and in a stronger way in AMPKa1 À/À MuSCs in a dose-dependent manner ( Figs 5B and C, and EV5C) without increase of MuSC apoptosis (Fig EV5E) , demonstrating the importance of LDH activity in the return to quiescence of MuSCs. Of note, this decrease in self-renewal in AMPKa1 À/À MuSCs after inhibition of LDH activity phenocopied the decreased self-renewal observed in WT MuSCs upon AMPK activation (Fig 4G-I) 
Discussion
Overall, our work shows that the master regulator of cellular energy, AMPKa1, regulates self-renewal of MuSCs, which is the first evidence of such a property for this pleiotropic kinase and the demonstration that energetic metabolism controls MuSC homeostasis. Our results show that the return to quiescence of MuSCs can be modulated by shifting their metabolism in an AMPKa1-dependent pathway through the regulation of a new functional target, LDH, that in turns controls the oxidative phosphorylation/aerobic glycolysis balance. Deletion of AMPKa1 in MuSCs drastically enhances their selfrenewal in vitro, ex vivo and in vivo (+367, +147 and +55%, respectively; Figs 1B and E, and 2E). To our knowledge, this is the strongest phenotype ever described in the literature regarding an increase of MuSC self-renewal. Few studies have related moderate increase of MuSC self-renewal during skeletal muscle regeneration Data are means AE SEM from at least three in vivo or in vitro experiments. *P < 0.05, **P < 0.01 versus WT. Cre/+ , which is a CRE recombinase preferentially expressed in already activated muscle cells (Shan et al, 2014) . Moreover, analysis was performed only at early time point (8 days) after injury and the status of Pax7 + cells has not been evaluated (i.e., quiescence, activation/proliferation, differentiation). In our study, MuSC selfrenewal is not affected in Pax7-LKB1 À/À mice as compared with
) mice, suggesting that AMPKa1 plays an LKB1-independent role in MuSC self-renewal during muscle regeneration.
Required-energetic shift for stem cell activation and differentiation has been suggested in HSCs. These later rely primarily on glycolysis to generate ATP and are less dependent on mitochondrial oxygen-consuming metabolism (Kim et al, 1998) than more differentiated cells (Simsek et al, 2010) . LKB1 deficiency in HSCs alters mitochondrial compartment and maximal oxygen consumption, an oxidative phosphorylation readout (Gan et al, 2010; Gurumurthy et al, 2010) . It has been previously evidenced that HSCs and MuSCs share common signaling pathways regulating their fate (i.e., FoxOs and Ang1/Tie2 signaling for the selfrenewal). Our results show a defect of mitochondria function in AMPKa1 À/À MuSCs, suggesting that they seem also to be metabolically close. A metabolic switch that conditions lineage commitment of HSCs has been recently identified (Oburoglu et al, 2014) . In fact, the commitment of human and murine HSCs to the erythroid lineage is dependent upon glutamine metabolism (Oburoglu et al, 2014) . However, it remains to determine whether metabolic flux directly affects adult stem cell fate. The data presented here indicate that tailoring metabolism via a shift from glycolysis to oxidative phosphorylation has the capability to regulate the return to quiescence of MuSCs in an AMPK-dependent pathway (Fig 3G-I) . Furthermore, the close environment of MuSCs gathers the same partners as those found in the cancer stem cell (CSC) niche and several signaling pathways regulating CSCs have been involved in the regulation of MuSC fate (AbouKhalil et al, 2009; Visvader & Lindeman, 2012; Yin et al, 2013) . It will be therefore of interest to determine whether AMPK activation, associated with tumor suppressor functions, can break CSC self-renewal by lifting their dormancy and pushing them toward differentiation. AMPK activation promotes a switch from rapid glucose uptake, glycolysis and lactate output (the Warburg effect observed in most tumoral cells) to oxidative metabolism, therefore reducing tumors in mouse (Faubert et al, 2013) . In this regard, it is interesting to note that AMPKa1 À/À MuSCs share common characteristics with CSCs regarding their proliferation and the Warburg-like effect (i.e., increase in aerobic glycolysis pathway). In our normoxic in vitro experimental design of MuSC fate, the increased release of lactate and the alteration of mitochondrial respiration revealed that AMPKa1 À/À MPCs are mainly glycolytic, producing energy independently of mitochondria and oxygen. Similar glycolytic status has been found in induced pluripotent, mesenchymal, and neural progenitor stem cells (Folmes et al, 2011; Candelario et al, 2013; de Meester et al, 2014) . To note, Fu et al (2015) showed a decrease in lactate release in proliferating conditions, claiming that AMPKa1-deficient MuSCs rely more on oxidative metabolism at the time of their activation. However, while MuSCs activate within 24 h after injury (Rodgers et al, 2014) , Fu et al (2015) analyzed MuSC activation 3 days after injury (Fu et al, 2015) , a time point characterized as the highest level of myogenic cell proliferation (Figs 1H and EV5F) (Murphy et al, 2011; Le Grand et al, 2012) . Intriguingly, while it has been demonstrated that Sirt1-AMPKa1 signaling pathway is required for MuSC activation and that early MuSC activation is intertwined with mitochondrial biogenesis and with mTORC1 signaling pathway inhibition (Rodgers et al, 2014; Tang & Rando, 2014) , Sirt1 inhibition and glycolysis (PKM1 to PKM2 switch) have been described to be crucial for MuSC activation (Ryall et al, 2015) . This may be explained by the various time points, and readouts have been used for the investigation of MuSC activation in these studies. Our study focused on later time points, long after activation and expansion phases of MuSCs and on the balance between differentiation and self-renewal. Our results suggest that at this time point, MuSCs skew their metabolism toward oxidative metabolism pathway to enter into differentiation. To clearly define intertwining between MuSC fate and metabolism, the use of new technological advances such as single cell-metabolomic profiling will The EMBO Journal AMPKa1-LDH regulates muscle stem cell fate Marine Theret et al lead to a deeper understanding of the novel cell fate determinants, which maintain MuSC stemness during skeletal muscle regeneration. Historically, LDH has been described as a non-limiting enzyme and as being expressed at high levels in the cells. This concept, established in the metabolism/biochemistry field, has been recently challenged since LDH activity is deregulated in CSCs (Augoff et al, 2015) . This may be due to a switch in LDH isoform expression (LDHB less active to LDHA more active) associated with VEGF secretion (Nishikawa et al, 1991; Kim et al, 2014) . Moreover, LDH tetramerization, which is required for LDH to be active, can be regulated by phosphorylation (Augoff et al, 2015) . Our results reveal that in adult stem cells (MuSCs and HSCs), LDH is regulated and acts as a limiting enzyme, as it was suggested in CSCs (Augoff et al, 2015) , whereas no regulation is noticed in differentiated cells. We showed that AMPKa1 modulates MuSC self-renewal specifically through the regulation of LDH activity, and not its expression. Interestingly, LDH activity increases in AMPKa1-deficient MuSCs and there is a functional direct link between AMPK activity, LDH activity, and the rate of MuSC renewal in vitro and in vivo. Furthermore, LDHA has been recently described as a putative new substrate of AMPK, with S274 and VHPVSTMIK identified by mass spectroscopy as phosphorylation site and peptide sequence, respectively (Schaffer et al, 2015) . Further investigations will identify whether several LDH isoforms are operative in MuSCs to control their differentiation/self-renewal balance. Finally, Faubert et al (2014) showed that HIF-1a (regulator of multiple enzymes of the glycolysis pathway) and LDHA protein are up-regulated in LKB1 À/À MEFs (Faubert et al, 2014) . However, protein level of HIF-1a is identical in WT and AMPKa1 À/À MPCs (data not shown), suggesting that AMPK regulates LDH activity independently of HIF-1a in our conditions. Interestingly, our data show the possibility of tailoring the metabolic makeup of MuSCs and of modulating their fate through the delivery of specific nutrients, indicating that the close environment of MuSC directly acts on their metabolism and fate. In this context, it will be essential to understand how MuSCs integrate changes from metabolic flux and other physiological parameters under homeostatic and stress conditions. For example, low oxygen tensions influence the maintenance of stem cell quiescence (Simon & Keith, 2008; Mohyeldin et al, 2010; Latil et al, 2012; Spencer et al, 2014) , and notably MuSCs (Latil et al, 2012) .
In conclusion, our findings report a new role of the master regulator of stress response pathway AMPKa1 in tailoring the metabolic makeup of MuSCs and in modulating their fate. Moreover, the present study identifies LDH as a new functional target of AMPKa1 in MuSCs, where it is a direct regulator by which the oxidative phosphorylation/aerobic glycolysis balance can be shifted to meet appropriate cellular needs.
Materials and Methods

Mouse experiments
Experiments were conducted on adult animals (8-25 weeks old). (Gan et al, 2010) . Mice were bred, and experiments were conducted in compliance with French and European legislation. Animal facilities are fully licensed by French authorities, and protocols have been validated by ethical committee. Activation of CreER T2 was caused by daily tamoxifen (2 mg/mouse, MP Biochemical) intraperitoneal (i.p.) injections during 4 days. The first injection was performed 1 week before the experiments. Control mice were injected with 1× PBS. Skeletal muscle injury was caused by intramuscular injection of CTX (Latoxan) in the TA muscle or in the GAS of male animals (50 ll per TA or 200 ll per GAS, 12 lM).
MuSC extraction, culture and treatments
Muscle stem cells (MuSCs) were extracted as previously described (Joe et al, 2010) . Briefly, mouse muscle hindlimbs from adult male or female animals were dissected and digested in collagenasedispase (Roche) at 37°C for 1 h. Erythrocytes were removed with Ammonium-Chloride-Potassium (ACP) lysis buffer (Lonza), and muscle mononucleated cells were stained with anti-CD45 (eBioscience), anti-CD31 (eBioscience), anti-Sca1 (eBioscience), anti-CD34 (eBioscience), and anti-a7integrin (AbLab). CD31/CD45/ Sca1 In some experiments, differentiation medium was replaced by glucose-and pyruvate-free DMEM (Life Technologies) containing 2% horse serum and supplemented with 25 mM glucose (SigmaAldrich), and 1 mM pyruvate (Life Technologies) (HGP) or 5 mM glucose (LG) or 10 mM galactose (Gal) (Sigma-Aldrich). After 2 days of differentiation, supernatants were harvested for lactate analysis and Pax7Ki67MyoD or active caspase-3 labeling was performed on cells.
MuSC labeling
Cells were fixed with 4% paraformaldehyde, permeabilized with 1× PBS 0.5% Triton X-100, and blocked with 1× PBS 4% bovine serum albumin (BSA) for at least 2 h at room temperature. Primary antibodies against Pax7 (Hybridoma Bank), Ki67 (Abcam) and MyoD (Santa Cruz), or active caspase-3 (Abcam) were incubated in 1× PBS 2% BSA overnight at 4°C. Secondary antibodies (Jackson Immunoresearch Inc.) were incubated 1 h at 37°C in 1× PBS, and streptavidin (Jackson Immunoresearch Inc.) was used to amplify Pax7 signal at 37°C for 30 min in 1× PBS. Nuclei were labeled with Hoechst (Sigma-Aldrich). 
AMPK activity
Freshly isolated MuSC was homogenized in lysis buffer as previously described (Sakamoto et al, 2006) . AMPK complexes were immunoprecipitated from an average number of 400,000 MuSCs using 1 lg of anti-AMPKa1 or AMPKa2 antibody (kind gift from D. Grahame Hardie, University of Dundee, Scotland, UK), and its phosphotransferase activity was determined toward AMARA peptide (AMARAASAAALARRR) as previously described (Hunter et al, 2011) .
In vivo macrophage skewing
Macrophage skewing was analyzed as previously described (Mounier et al, 2013 (Starck et al, 2010) . Briefly, total bone marrow was flushed from tibiae and femurs with Iscove's modified Dulbecco's medium (IMDM) containing 2% FBS. Erythrocytes were removed with lysis buffer ACK and Lin + cells were removed by a magnetic cell sort using Lineage Cell Depletion Kit (Miltenyi Biotec) supplemented with anti-CD19 (eBiosciences), anti-CD3 (BD Pharmingen), anti-IL7R (eBiosciences), and anti-Ter119 (eBiosciences). Lin À cells were labeled with anti-cKit (BD Pharmingen) and anti-Sca1 (eBiosciences) antibodies, and LSK cells were sorted using Aria I cytometer (BD).
PCR for AMPK deletion
MuSCs (CD31/CD45/Sca1 À CD34/a7integrin + ) and non-myogenic cells (CD45/CD31/Sca1 + ) were extracted from muscle hindlimbs as previously described, and specific deletion of AMPKa1 was performed as previously described (Mounier et al, 2013) .
Isolated myofibers
Single myofibers were isolated from extensor digitorum longus and plantaris as previously described (Abou-Khalil et al, 2009).
Western blot analysis
Tibialis anterior, soleus, gastrocnemius, heart and liver from ) mice were lyzed in lysis buffer (Mammalian Cell Lysis Kit, Sigma-Aldrich). 50 lg of each lysate was subjected to 10% acrylamide gel electrophoresis, and transfer was then run overnight on nitrocellulose membrane (Hybond-Cextra, Amersham Biosciences). Anti-AMPKa1 antibody (kindly given by Grahame Hardie) was incubated overnight at 4°C. Anti-sheep antibody coupled to HRP was then incubated for 2 h at room temperature, and membrane was revealed with ECL west femto (Thermo Scientific).
In vivo electroporation
Empty plasmid (pcDNA3) or plasmid encoding for LDH A (pcDNA-3.2-DEST-LDHA-V5) [5 lg of plasmid in 50 ll of NaCl (900 mM)] was electroporated into regenerating TA muscle from WT mice, 5 days after CTX injury (Mounier et al, 2009 ). Skeletal muscle regeneration was analyzed 28 days after CTX injury as described below.
Histological and immunohistochemical analysis
For histological analysis, muscles were harvested, snap-frozen in nitrogen-chilled isopentane, and kept at À80°C until use. 8-lm-thick cryosections were prepared for hematoxylin-eosin (HE) staining or for Pax7Ki67MyoD labeling. For Pax7Ki67MyoD labeling, muscle cryosections were fixed and permeabilized in 100% methanol for 7 min at À20°C. After three washes with 1× PBS, muscle cryosections were sequentially incubated for 5 min in two baths of citric acid (10 mM, pH 6) at 90°C. After three washes with 1× PBS, muscle cryosections were saturated with 1× PBS 4% BSA for at least 2 h at room temperature (RT) and then incubated with antibodies against Pax7 (Hybridoma bank), Ki67 (Abcam) and MyoD (Santa Cruz) overnight at +4°C in 1× PBS 2% BSA. Secondary antibodies (Jackson Immunoresearch Inc.) were incubated 1 h at 37°C in 1× PBS, and streptavidin (Jackson Immunoresearch Inc.) was used to amplify Pax7 signal (37°C for 30 min in 1× PBS). Nuclei were labeled with Hoechst (Sigma-Aldrich).
Image capture and analysis HE-stained muscle sections were entirely recorded with a Zeiss Axiospot microscope connected to an AxioCam Icc5 (Zeiss) camera at 10× and randomly at 20× magnification. For each condition of each experiment, 5 AE 1 randomly chosen fields were counted, representing 986 AE 69 myofibers. Quantitative analysis of skeletal muscle regeneration (number of nuclei per fiber and number of fibers per muscle) was performed using ImageJ software. Crosssectional area (CSA) of regenerating myofibers was quantified as described in Liu et al (2013) and Qi et al (2012) and was expressed in lm². Fluorescent-labeled muscle sections were recorded with a Zeiss Imager Z1 microscope connected to a Coolsnap Myo (Photometrics) camera at 20× magnification. For each condition of each experiment, 9 AE 1 randomly chosen fields were counted, representing 64 AE 4 cells. The number of labeled myogenic cells was calculated using ImageJ software and was expressed as a percentage of The EMBO Journal AMPKa1-LDH regulates muscle stem cell fate Marine Theret et al total myogenic cells or related to the number of fibers per muscle section. In vitro fluorescent immunolabelings were recorded with a Zeiss Observer Z1 microscope connected to a Coolsnap HQ² (Photometrics) camera at 10× magnification. For each condition of each experiment, 5 AE 1 randomly chosen fields were counted, representing 1,297 AE 213 cells. The number of labeled nuclei was calculated using ImageJ software and expressed as a percentage of total nuclei. Fusion index was calculated as the number of nuclei within myotubes divided by the total number of nuclei.
Muscle precursor cell culture
Myogenic precursor cells were obtained as previously described (Mounier et al, 2009 ) from TA and gastrocnemius muscles and cultured using standard conditions in proliferating medium (DMEM/F12, 20% FBS, and 2% G/Ultroser). To analyze mitochondrial membrane potential, glycolytic flux, and apoptosis, MPCs were seeded at 3,000 cell/cm 2 on gelatin (0.02%) coat in proliferating medium. 24 h later, cells were incubated for 3 h with 20 lM 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose (2-NBDG, Life Technologies) or for 4 h with 10 À6 M staurosporine (SigmaAldrich). 2-NBDG (465/540 nm) and apoptosis (Annexin-V-FLUOS Staining Kit, Roche) were analyzed using FACSCanto II cytometer (BD) and FlowJo software. For pyruvate kinase (PK), LDH, OCR, and RT-qPCR assay, MPCs were seeded at 60,000 cell/cm 2 on gelatin-coated plates (0.02%) and lysates were harvested 6 h later. For lactate assay, supernatants were harvested 24 h after seeding. For adhesion study, MPCs were labeled with PKH27 dye (SigmaAldrich) before plating and cell adhesion was quantified 6 h later by fluorimetry using FLUOstar OPTIMA (BMG LABTECH).
Lactate dehydrogenase activity assay
Lactate dehydrogenase activity was quantified as previously described (Ferretti et al, 1997) . Briefly, cells were lysed in phosphate buffer containing 0.05% BSA. After three rounds of freezing/ defreezing, lysates were centrifuged and protein content was quantified with BCA kit (Pierce). LDH activity was measured by fluorimetry using a spectrophotometer UVmc 2 (Safas) and expressed as micromoles of substrate per minute per gram of protein (U/g) or normalized to WT and expressed as arbitrary units (a.u.).
Lactate assay
Lactate concentration in culture medium was measured as previously described (de Meester et al, 2014) . Briefly, cell supernatant was recovered and treated with perchloric acid (10% final), and pH was neutralized (pH 7) with KOH/KHCO 3 . Protein content was quantified using BCA kit (Pierce), and lactate concentration was measured by fluorimetry using a spectrophotometer UVmc² (Safas). Lactate concentration was normalized to WT and expressed as arbitrary units (a.u.).
Citrate synthase activity assay
Six hours after plating, WT and AMPKa1 À/À MPCs were lyzed and citrate synthase activity was measured as previously described (Srere & Brooks, 1969; Vial et al, 2011) .
Pyruvate kinase activity assay
Pyruvate kinase activity was quantified as previously described (Christofk et al, 2008) . Briefly, cells were lyzed in buffer [50 mM Tris-HCl pH 7.5, 1 mM EDTA, 150 mM NaCl, 1% NP-40, 1 mM DTT and protease inhibitors (Roche)] for 30 min on ice. Protein content was quantified using BCA kit (Pierce), and PK activity was measured in reaction buffer (50 mM Tris-HCl pH 7.5, 100 mM KCl, 5 mM MgCl 2 , 0.6 mM ADP (Sigma), 0.5 mM PEP (Sigma), 0.18 mM NADH (Sigma), 10 lM FBP (Sigma), and 10 units of LDH) by fluorimetry using a spectrophotometer UVmc 2 (Safas). PK activity was normalized to WT and expressed as arbitrary units (a.u.).
Oxygen consumption rate and extracellular acidification rate
Oxygen consumption rate (OCR, pm/min) and extracellular acidification rate (ECAR, mpH/min) were measured using a Seahorse Bioscience XF96 extracellular. MPC medium was replaced by XF assay medium and supplemented with 17 mM glucose (SigmaAldrich), 1 mM GlutaMax (Life technologies), and 0.5 mM pyruvate (Life technologies). OCR and ECAR were measured every 7 min over 140 min. Minimal OCR was measured after one injection of 2 lg/ll of oligomycin, and maximal OCR was measured after three injections of 0.5 mM carbonyl cyanide m-chlorophenylhydrazone (CCCP).
TOM22 labeling
WT and AMPKa1 À/À MPCs were seeded at 60,000 cells/cm 2 . Six hours after plating, TOM22 labeling was performed. Briefly, MPCs were fixed for 10 min at room temperature with 1× PBS 4% PFA, then were permeabilized for 10 min with 1× PBS 0.5% Triton X-100, and were incubated with anti-TOM22 antibodies (SigmaAldrich) overnight at +4°C in 1× PBS containing 2% BSA. Secondary antibodies (Jackson Immunoresearch Inc.) were added for 1 h at 37°C. Finally, nuclei were labeled with Hoechst (Sigma-Aldrich).
HeLa cell line culture
HeLa cell line was cultured in DMEM high glucose (Life Technologies), 20% FBS. Cells were transfected with a plasmid encoding for LDH A (pcDNA-3.2-DEST-LDHA-V5) using the CAPHOS kit (SigmaAldrich). Forty-eight hours later, AMPK was activated with 1 lM of compound 991 and lysates were harvested 15 min after activation for LDH activity assay.
Reverse transcription and quantitative polymerase chain reaction
Total RNA was extracted using Trizol reagent (Life Technologies) and was separated from protein with chloroform. RNA was reversetranscribed using Superscript II Reverse Transcriptase (Invitrogen). qPCR was carried out on Bio-Rad CFX. Reaction occurred in a final volume of 20 ll: 3 ll of cDNA, 10 ll of LightCycler â 480 SYBR Green I Master and 10 lM of primers. After initial denaturation, amplification was performed at 95°C (10 s) 60°C (5 s) 72°C (10 s) for 45 cycles. Calculation of relative expression was determined by the Bio-Rad CFX manager software, and fold change was normalized against the housekeeping gene cyclophilin.
qPCR primers ampka1 forward TACTCAACCGGCAGAAGATTCG, ampka1 reverse AGACGGCGGCTTTCCTTTT ldha forward TGTCTCCAGCAAAGACTACTGT, ldha reverse GACTG TACTTGACAATGTTGGGA pgc1a forward AAGTGGTGTAGCGACCAATCG, pgc1a reverse AATG AGGGCAATCCGTCTTCA pgc1b forward TGACGTGGACGAGCTTTCAC, pgc1b reverse TGAC GTGGACGAGCTTTCAC pkm1 forward GCATCATGCTGTCTGGAGAA, pkm1 reverse GTTCC TCGAATAAGCTGCAAGT pkm2 forward TGTCTGGAGAAACAGCCAAG, pkm2 reverse CTCG CACAAGCTCTTCAAAC cyclophilin forward GTGACTTTACACGCCATAATG, cyclophilin reverse ACAAGATGCCAGGACCTGTAT
Statistical analyses
All experiments were performed using at least three different cultures or animals in independent experiments. Statistical analyses were performed with Prism software (GraphPad). The Student's ttest was used for statistical analyses. P < 0.05 was considered significant. Data are means AE SEM.
Expanded View for this article is available online.
